A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam
Description
CONCLUSIONS: MOV caused a reduction in the risk of hospitalization or death in mild COVID-19 patients, and molnupiravir was also found to be well tolerated and safe without any major adverse events during the administration period.
